Table 2 Examinations and treatments during hospitalization of the study patients according to status of coronary artery disease and sex
Variables, N (missing)a | CAD (n = 664) | No CAD (n = 3242) | P-value | Men | Women | ||||
|---|---|---|---|---|---|---|---|---|---|
CAD (n = 500) | No CAD (n = 2564) | P-value | CAD (n = 164) | No CAD (n = 678) | P-value | ||||
Heart rate (beats per min), 4 | 84.0 (20.0) | 87.0 (19.0) | < 0.001 | 84.0 (22.0) | 87.0 (20.0) |  < 0.001 | 85.0 (18.0) | 87.0 (18.0) | 0.131 |
Respiratory rate (breaths per min), 12 | 20.0 (2.0) | 20.0 (2.0) | 0.595 | 20.0 (2.0) | 20.0 (2.0) | 0.705 | 20.0 (2.0) | 20.0 (2.0) | 0.634 |
Blood gasb, 1983 | |||||||||
 pH | 7.42 (0.05) | 7.41 (0.05) | 0.430 | 7.41 (0.05) | 7.41 (0.05) | 0.941 | 7.42 (0.04) | 7.42 (0.05) | 0.326 |
 PaO2 (mmHg) | 71.0 (19.0) | 70.0 (19.0) | 0.428 | 70.9 (19.0) | 71.0 (19.0) | 0.511 | 71.0 (19.0) | 68.0 (18.0) | 0.445 |
 PaCO2 (mmHg) | 41.2 (9.0) | 41.4 (10.0) | 0.426 | 41.0 (9.0) | 41.4 (10.0) | 0.290 | 42.0 (10.0) | 41.8 (9.0) | 0.929 |
Blood routine, 48 | |||||||||
 WBCs (× 109/L) | 7.20 (3.83) | 7.21 (3.75) | 0.451 | 7.38 (3.82) | 7.26 (3.84) | 0.447 | 7.01 (3.90) | 7.12 (3.54) | 0.739 |
 Neutrophils (%) | 70.0 (15.5) | 70.1 (17.6) | 0.737 | 71.3 (16.0) | 70.3 (17.8) | 0.554 | 68.6 (13.2) | 69.5 (16.8) | 0.823 |
 Lymphocytes (%) | 19.0 (13.0) | 18.7 (14.6) | 0.698 | 18.1 (12.7) | 18.2 (14.7) | 0.500 | 21.2 (12.5) | 20.9 (14.0) | 0.983 |
 NLR | 3.7 (3.7) | 3.7 (4.3) | 0.744 | 3.8 (4.1) | 3.9 (4.6) | 0.545 | 3.3 (2.8) | 3.3 (3.1) | 0.900 |
 Eosinophils (%) | 1.6 (2.6) | 1.4 (2.8) | 0.030 | 1.6 (2.7) | 1.5 (2.9) | 0.037 | 1.4 (2.5) | 1.3 (2.5) | 0.404 |
 Red blood cells (× 1012/L) | 4.48 (1.00) | 4.52 (1.00) | 0.063 | 4.51 (1.00) | 4.58 (1.00) | 0.033 | 4.42 (1.00) | 4.35 (1.00) | 0.538 |
 Hemoglobins (g/L) | 136.0 (22.0) | 138.0 (24.0) | 0.056 | 137.0 (22.0) | 140.0 (24.0) | 0.028 | 131.0 (19.0) | 130.0 (21.0) | 0.257 |
 Platelets (× 109/L) | 199.0 (80.0) | 208.0 (96.0) | 0.127 | 196.0 (80.5) | 204.0 (97.0) | 0.116 | 208.0 (92.5) | 219.5 (90.8) | 0.501 |
Blood biochemistry, 127 | |||||||||
 ALT (U/L) | 16.0 (11.8) | 16.6 (12.0) | 0.160 | 17.0 (12.4) | 17.0 (12.9) | 0.298 | 15.0 (9.2) | 15.0 (11.0) | 0.653 |
 AST (U/L) | 19.0 (9.0) | 19.5 (9.5) | 0.037 | 19.2 (9.7) | 19.7 (9.4) | 0.250 | 17.5 (8.7) | 19.0 (10.0) | 0.040 |
 BUN (mmol/L) | 5.7 (2.9) | 5.4 (2.6) | < 0.001 | 5.8 (2.9) | 5.5 (2.6) | 0.001 | 5.1 (2.6) | 4.8 (2.4) | 0.029 |
 Cr (μmol/L) | 72.0 (29.3) | 70.4 (23.1) | 0.002 | 76.5 (29.8) | 73.0 (21.3) |  < 0.001 | 59.2 (23.0) | 58.7 (19.9) | 0.675 |
 Blood glucose (mmol/L), 137 | 5.6 (1.9) | 5.5 (1.8) | 0.020 | 5.7 (2.0) | 5.5 (1.9) | 0.037 | 5.6 (1.8) | 5.4 (1.7) | 0.251 |
 NT-proBNP (pg/ml), 2997 | 230.6 (584.0) | 113.0 (220.0) |  < 0.001 | 236.0 (577.0) | 111.0 (219.0) |  < 0.001 | 201.0 (558.0) | 119.0 (230.0) | 0.187 |
 CRP (mg/L), 1610 | 5.0 (12.0) | 4.7 (15.0) | 0.793 | 5.0 (15.0) | 5.0 (16.0) | 0.950 | 4.3 (9.0) | 4.3 (11.0) | 0.731 |
 PCT (ng/ml), 1693 | 0.06 (0.10) | 0.05 (0.08) | 0.610 | 0.06 (0.10) | 0.05 (0.08) | 0.727 | 0.05 (0.07) | 0.05 (0.07) | 0.660 |
 SABD, 0 | 472 (71.1%) | 2447 (75.5%) | 0.019 | 357 (71.4%) | 1941 (75.7%) | 0.042 | 115 (70.1%) | 506 (74.6%) | 0.277 |
 LAMA, 0 | 53 (8.0%) | 334 (10.3%) | 0.074 | 44 (8.8%) | 271 (10.6%) | 0.260 | 9 (5.5%) | 63 (9.3%) | 0.123 |
 LABA, 0 | 50 (7.5%) | 387 (11.9%) | 0.001 | 41 (8.2%) | 309 (12.1%) | 0.014 | 9 (5.5%) | 78 (11.5%) | 0.031 |
 ICS, 0 | 71 (10.7%) | 441 (13.6%) | 0.043 | 56 (11.2%) | 350 (13.7%) | 0.149 | 15 (9.1%) | 91 (13.4%) | 0.151 |
 Nebulized corticosteroids, 0 | 438 (66.0%) | 2061 (63.6%) | 0.249 | 324 (64.8%) | 1613 (62.9%) | 0.447 | 114 (69.5%) | 448 (66.1%) | 0.408 |
 Systemic corticosteroids, 0 | 180 (27.1%) | 1091 (33.7%) | 0.001 | 144 (28.8%) | 876 (34.2%) | 0.022 | 36 (22.0%) | 215 (31.7%) | 0.017 |
 Antibiotics, 0 | 577 (86.9%) | 2807 (86.6%) | 0.851 | 426 (85.2%) | 2208 (86.1%) | 0.622 | 151 (92.1%) | 599 (88.3%) | 0.209 |
 ICU admission, 0 | 13 (2.0%) | 29 (0.9%) | 0.022 | 12 (2.4%) | 25 (1.0%) | 0.013 | 1 (0.6%) | 4 (0.6%) | 1.000 |